Wells Fargo Upgrades Edwards Lifesciences (EW) to Outperform; Final TAVR NCD A Win, More Catalysts To Follow
Go back to Wells Fargo Upgrades Edwards Lifesciences (EW) to Outperform; Final TAVR NCD A Win, More Catalysts To Follow| Edwards Lifesciences (NYSE: EW) | Delayed: 90.78 -0.82 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.60 | 52 Week High | $166.87 | |||
| Open | $90.84 | 52 Week Low | $72.20 | |||
| Day High | $91.58 | P/E | 26.39 | |||
| Day Low | $90.59 | EPS | $3.44 | |||
| Volume | 671,814 | |||||
